Stereological measurement of tumour volumes confirmed the development of significantly larger tumours in brains transplanted with GSCs treated with TET3 shRNA, compared with that in brains transplanted with control GSCs (Fig. 7j). The gene discussed is TET3; the disease is neoplasm.